Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ·Healthcare·Biotechnology
$29.12
-0.99%
Mkt Cap $1.82B
Analyst Ratings
Buy
12
Hold
2
Sell
0
Price Target (27 analysts)
$41.33
Range $32.00 – $55.00
Implied Upside
+41.9%
Consensus $41.33 vs current $29.12
NASDAQ·Healthcare·Biotechnology
$29.12
-0.99%
Mkt Cap $1.82B
Buy
12
Hold
2
Sell
0
Price Target (27 analysts)
$41.33
Range $32.00 – $55.00
+41.9%
Consensus $41.33 vs current $29.12